The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - The past few months have been eventful ones for Biogen Idec (NASDAQ:BIIB), as the company awaits the FDA’s decision on BG-12 and continues to build … Continue Reading
Read nowLong Ideas - Merge Healthcare (NASDAQ:MRGE) is back in the news with Reuters reporting that the company’s plan to explore strategic alternatives has attracted at least five private … Continue Reading
Read nowLong Ideas - Keryx BioPharmaceuticals (NASDAQ:KERX) updated investors Thursday morning on both its Zerenex development program and its 3Q financials, reiterating that pivotal Phase 3 data for the … Continue Reading
Read nowLong Ideas - Palatin Technologies (AMEX:PTN) announced this morning that its Phase IIb trial for bremelanotide met its primary endpoint, as well as secondary endpoints, for the treatment … Continue Reading
Read nowLong Ideas - Endocyte (NASDAQ:ECYT)Â recently confirmed that the Marketing Authorization Application (MAA) filing process for vintafolide and etarfolatide in Europe is set to be completed by the end … Continue Reading
Read nowLong Ideas - Orexigen Therapeutics (NASDAQ:OREX) will be releasing its third quarter earnings report after the market’s close Wednesday night, and with all of the hoopla surrounding obesity … Continue Reading
Read nowLong Ideas - On the heels of ponatinib’s Priority Review announcement, Ariad Pharmaceuticals (NASDAQ:ARIA) reported 3Q financial results Wednesday, and on its related conference call emphasized the preparation … Continue Reading
Read now
